Nicollet Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Sell
5,699
-232
-4% -$116K 1.16% 28
2025
Q4
$2.89M Buy
5,931
+55
+0.9% +$25.6K 0.91% 33
2025
Q3
$2.46M Sell
5,876
-266
-4% -$89.5K 0.8% 34
2025
Q2
$1.76M Sell
6,142
-190
-3% -$56.8K 0.59% 39
2025
Q1
$1.95M Buy
6,332
+526
+9% +$180K 0.69% 38
2024
Q4
$2.05M Sell
5,806
-27
-0.5% -$9.92K 0.7% 38
2024
Q3
$2.09M Buy
5,833
+61
+1% +$20.6K 0.72% 38
2024
Q2
$1.84M Sell
5,772
-151
-3% -$40K 0.69% 37
2024
Q1
$1.36M Buy
5,923
+28
+0.5% +$6.32K 0.5% 40
2023
Q4
$1.3M Buy
5,895
+107
+2% +$24.7K 0.53% 41
2023
Q3
$1.31M Buy
5,788
+115
+2% +$26.5K 0.59% 37
2023
Q2
$1.25M Buy
5,673
+133
+2% +$29.5K 0.56% 40
2023
Q1
$1.24M Sell
5,540
-250
-4% -$61.6K 0.65% 35
2022
Q4
$1.61M Sell
5,790
-44
-0.8% -$11.1K 0.93% 33
2022
Q3
$1.22M Buy
5,834
+185
+3% +$41.4K 0.67% 36
2022
Q2
$1.33M Buy
5,649
+69
+1% +$14K 0.72% 34
2022
Q1
$1M Sell
5,580
-241
-4% -$45.9K 0.44% 38
2021
Q4
$1.26M Sell
5,821
-124
-2% -$24.3K 0.51% 37
2021
Q3
$1.1M Buy
5,945
+3
+0.1% +$591 0.46% 42
2021
Q2
$1.07M Sell
5,942
-23
-0.4% -$4.38K 0.43% 44
2021
Q1
$998K Sell
5,965
-22
-0.4% -$3.67K 0.44% 45
2020
Q4
$909K Buy
5,987
+209
+4% +$27.4K 0.41% 43
2020
Q3
$584K Sell
5,778
-152
-3% -$16.7K 0.3% 47
2020
Q2
$718K Buy
5,930
+45
+0.8% +$5.06K 0.4% 44
2020
Q1
$558K Buy
5,885
+55
+0.9% +$5.23K 0.41% 44
2019
Q4
$514 Sell
5,830
-215
-4% -$18.9K 0.24% 60
2019
Q3
$482K Buy
6,045
+55
+0.9% +$4.43K 0.31% 61
2019
Q2
$468K Sell
5,990
-30
-0.5% -$2.81K 0.29% 59
2019
Q1
$707K Hold
6,020
0.47% 52
2018
Q4
$656K Sell
6,020
-50
-0.8% -$5.8K 0.52% 51
2018
Q3
$776K Buy
6,070
+195
+3% +$24.1K 0.51% 50
2018
Q2
$665K Buy
5,875
+75
+1% +$8.24K 0.48% 54
2018
Q1
$652K Hold
5,800
0.51% 52
2017
Q4
$858K Buy
+5,800
New +$737K 0.71% 42

Other funds holding UTHR